This content is machine translated Baxdrostat – a new class of drugs for treating difficult-to-control hypertension First Aldosterone Synthase Inhibitor Is Here It is the first new class of antihypertensive drugs in years: On May 18, 2026, the U.S. Food and Drug Administration (FDA) approved Baxdrostat (Baxfendy) as the first and only...…
